Product Information
VANCOMYCIN 25 MG/ML ORAL SOLN is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $0.6729 per ML under NDC 52536010405. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Jan 26, 2018. Its Orange Book therapeutic-equivalence code is AA.
Manufacturer
Wilshire Pharmaceuticals Inc.NDC
52536010405
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Authorized Generic (NDA)
FDA Application
NDA208910FDA Approved
1/26/2018
TE Code
AA
On Market Since
3/31/2023
Price Statistics
The NADAC for VANCOMYCIN 25 MG/ML ORAL SOLN has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 3.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6729 per ML |
|---|---|
| All-time high | $0.7049 (Jun 12, 2024) |
| All-time low | $0.4321 (Jul 23, 2025) |
| 52-week high | $0.6729 |
| 52-week low | $0.4559 |
| Median price | $0.5213 |
| Average price | $0.5463 |
| Largest weekly change | -8.9% (Sep 18, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Wilshire Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
vancomycin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VANCOMYCIN 25 MG/ML ORAL SOLN?
The current National Average Drug Acquisition Cost (NADAC) for VANCOMYCIN 25 MG/ML ORAL SOLN, manufactured by Wilshire Pharmaceuticals Inc., is $0.6729 per ML (NDC 52536010405), effective Sep 30, 2026.
How has the price of VANCOMYCIN 25 MG/ML ORAL SOLN changed over time?
Over the history we have for it, the NADAC for VANCOMYCIN 25 MG/ML ORAL SOLN has declined 3.8%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for VANCOMYCIN 25 MG/ML ORAL SOLN?
Since Apr 17, 2024, the NADAC for VANCOMYCIN 25 MG/ML ORAL SOLN has ranged from a low of $0.4321 (Jul 23, 2025) to a high of $0.7049 (Jun 12, 2024), with a median of $0.5213 per ML.
Are there cheaper alternatives to VANCOMYCIN 25 MG/ML ORAL SOLN?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VANCOMYCIN 25 MG/ML ORAL SOLN, is $0.3900 per ML — about 42% below VANCOMYCIN 25 MG/ML ORAL SOLN.
Who manufactures VANCOMYCIN 25 MG/ML ORAL SOLN?
VANCOMYCIN 25 MG/ML ORAL SOLN (NDC 52536010405) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.